ADC Therapeutics

Home » ADC Therapeutics

IPO

ADC Therapeutics

Biotechnology

We are a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates (“ADCs”) for patients suffering from hematological malignancies and solid tumors.

Symbol

ADCT

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
MORGAN STANLEY & CO. LLC,COWEN AND COMPANY, LLC

To view the prospectus for ADC Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253